Avicanna Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Peru
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that, through its majority-owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH”), it has completed its first commercial export into Peru of high concentration THC, full spectrum psychoactive cannabis crude oil, marketed under Avicanna’s Aureus™ brand, to Peru.
- Believed to be the first commercial export of psychoactive THC cannabis extract from Colombia to Peru.
- (SMGH), it has completed its first commercial export into Peru of high concentration THC, full spectrum psychoactive cannabis crude oil, marketed under Avicannas Aureus brand, to Peru.
- Lucas Nosiglia, President of Avicanna LATAM S.A.S., commented: We are pleased to enter the growing Peruvian market and integrate Peru into our rapidly advancing supply chain and commercial platform.
- Additionally, under the Aureus brand, standardized cannabis extracts and feminized seeds are made available to cultivation, cosmetic and pharmaceutical partners around the world.